Persistant Post-mastectomy Pain in Breast Cancer : Incidence and Risk Factors
Incidence and Risk Factors of Chronic (Persistant) Post-surgical Pain in Oncological Breast Surgery : a Prospective Cohort Study in a National Institute of Oncology
1 other identifier
observational
722
1 country
2
Brief Summary
Post Mastectomy Pain Syndrome (PMPS) is a major complication of breast surgery responsible for depression and disability. The project consists of a prospective cohort on patients going for oncological breast surgery at National Institute of Oncology of Rabat. Chronic postoperative pain (CPP) remains a disturbing and obscure clinical problem, which could last for more than 3 months after surgery. The aim of present study was to assess the prevalence of CPP, investigate its impact on life quality and explore its potential risk factors. After informed consent was signed, patients receiving surgery under general anesthesia in Peking Union Medical College Hospital and other medical centers participating in this study during 2018 will be included. Patients' preoperative information will be collected from medical record, including basic demographic data, primary disease and previous chronic diseases. Intraoperative information will be obtained from anesthesia record, including surgical scope, duration, length and location of incisions and blood loss. Acute pain will be evaluated in the ward of the department of surgery, when an app will be installed on patients' mobile phones. Our long-term postoperative follow-up would be performed by sending out survey questionnaires via this app in the 4th, 8th, 16th, 32th, and 48th weeks after surgery. The survey covers questions regarding the intensity, characteristic, location and impact on daily activities of CPP. Information regarding treatment of CPP will also be collected, if any. All the data gained will be summarized in our database and analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2018
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2020
CompletedFirst Submitted
Initial submission to the registry
December 15, 2020
CompletedFirst Posted
Study publicly available on registry
December 21, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2021
CompletedJuly 20, 2021
July 1, 2021
1.7 years
December 15, 2020
July 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-mastectomy pain
Assessed via breast pain questionnaire, including severity, frequency, related symptoms, and functional impairment
preoperative-3months postoperative
Study Arms (1)
Patients receiving surgery breast surgery for cancer at National Institute of Oncology
No intervention will be administered
Eligibility Criteria
Patients undergo breast surgery at National Institute of Oncology (Sheikha Fatma center)
You may qualify if:
- Willingness and ability to sign an informed consent document
- More than 18 years of age
- All American Society of Anesthesiology classes
- Patient undergo for breast surgery
You may not qualify if:
- Patients who expressed their refusal to participate in the study
- Patients unable to express their non-opposition to participating in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
National Institute of Oncology of Rabat
Rabat, 10170, Morocco
National Institut of Oncology, Surgical oncology department
Rabat, Morocco
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abdelilah Ghannam, MD
Mohammed V University in Rabat
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 15, 2020
First Posted
December 21, 2020
Study Start
December 10, 2018
Primary Completion
September 8, 2020
Study Completion
March 7, 2021
Last Updated
July 20, 2021
Record last verified: 2021-07